Neutropenia risk factors: Difference between revisions
Jump to navigation
Jump to search
m (Template) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Neutropenia }} | {{ Neutropenia }} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{DG}} | ||
==Overview== | ==Overview== | ||
At-risk populations include those undergoing cytotoxic chemotherapy or other myelosuppressive medications, however a benign form of mild neutropenia is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia. | |||
==Risk Factors== | ==Risk Factors== | ||
*Medications | |||
*Hematologic malignancies | |||
*Autoimmune disorders | |||
*Infections | |||
*Black, Yemenite, West Indian, or Arab Jordanian ethnicity | |||
==References== | ==References== |
Revision as of 16:58, 24 October 2016
Neutropenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neutropenia risk factors On the Web |
American Roentgen Ray Society Images of Neutropenia risk factors |
Risk calculators and risk factors for Neutropenia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]
Overview
At-risk populations include those undergoing cytotoxic chemotherapy or other myelosuppressive medications, however a benign form of mild neutropenia is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia.
Risk Factors
- Medications
- Hematologic malignancies
- Autoimmune disorders
- Infections
- Black, Yemenite, West Indian, or Arab Jordanian ethnicity